219 related articles for article (PubMed ID: 31176541)
1. The advances in brucellosis vaccines.
Hou H; Liu X; Peng Q
Vaccine; 2019 Jul; 37(30):3981-3988. PubMed ID: 31176541
[TBL] [Abstract][Full Text] [Related]
2. Development and trial of vaccines against
Lalsiamthara J; Lee JH
J Vet Sci; 2017 Aug; 18(S1):281-290. PubMed ID: 28859268
[TBL] [Abstract][Full Text] [Related]
3. Research progress in live attenuated Brucella vaccine development.
Wang Z; Wu Q
Curr Pharm Biotechnol; 2013; 14(10):887-96. PubMed ID: 24372253
[TBL] [Abstract][Full Text] [Related]
4. Rough vaccines in animal brucellosis: structural and genetic basis and present status.
Moriyón I; Grilló MJ; Monreal D; González D; Marín C; López-Goñi I; Mainar-Jaime RC; Moreno E; Blasco JM
Vet Res; 2004; 35(1):1-38. PubMed ID: 15099501
[TBL] [Abstract][Full Text] [Related]
5. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
Truong QL; Cho Y; Kim K; Park BK; Hahn TW
Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
[TBL] [Abstract][Full Text] [Related]
6. Towards a Brucella vaccine for humans.
Perkins SD; Smither SJ; Atkins HS
FEMS Microbiol Rev; 2010 May; 34(3):379-94. PubMed ID: 20180858
[TBL] [Abstract][Full Text] [Related]
7. A history of the development of Brucella vaccines.
Avila-Calderón ED; Lopez-Merino A; Sriranganathan N; Boyle SM; Contreras-Rodríguez A
Biomed Res Int; 2013; 2013():743509. PubMed ID: 23862154
[TBL] [Abstract][Full Text] [Related]
8. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
[TBL] [Abstract][Full Text] [Related]
9. [The application and research advances of Brucella vaccines].
Ding JB; Mao KR; Cheng JS; Dai ZH; Jiang YW
Wei Sheng Wu Xue Bao; 2006 Oct; 46(5):856-9. PubMed ID: 17172046
[TBL] [Abstract][Full Text] [Related]
10. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
[TBL] [Abstract][Full Text] [Related]
11. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
Gupta S; Singh D; Gupta M; Bhatnagar R
Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
[TBL] [Abstract][Full Text] [Related]
12. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
[TBL] [Abstract][Full Text] [Related]
14. Meta-Analysis and Advancement of Brucellosis Vaccinology.
Carvalho TF; Haddad JP; Paixão TA; Santos RL
PLoS One; 2016; 11(11):e0166582. PubMed ID: 27846274
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic and protective antigens of Brucella as vaccine candidates.
Masjedian Jezi F; Razavi S; Mirnejad R; Zamani K
Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():29-36. PubMed ID: 31300122
[TBL] [Abstract][Full Text] [Related]
16. Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus.
Gómez L; Alvarez F; Betancur D; Oñate A
Vaccine; 2018 May; 36(21):2928-2936. PubMed ID: 29685597
[TBL] [Abstract][Full Text] [Related]
17. Comparison between immune responses and resistance induced in BALB/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis bv. 3.
Hamdy ME; El-Gibaly SM; Montasser AM
Vet Microbiol; 2002 Aug; 88(1):85-94. PubMed ID: 12119140
[TBL] [Abstract][Full Text] [Related]
18. Laboratory animal models for brucellosis research.
Silva TM; Costa EA; Paixão TA; Tsolis RM; Santos RL
J Biomed Biotechnol; 2011; 2011():518323. PubMed ID: 21403904
[TBL] [Abstract][Full Text] [Related]
19. Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease.
Martins Rda C; Irache JM; Gamazo C
Expert Rev Vaccines; 2012 Jan; 11(1):87-95. PubMed ID: 22149711
[TBL] [Abstract][Full Text] [Related]
20. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51.
Ashford DA; di Pietra J; Lingappa J; Woods C; Noll H; Neville B; Weyant R; Bragg SL; Spiegel RA; Tappero J; Perkins BA
Vaccine; 2004 Sep; 22(25-26):3435-9. PubMed ID: 15308369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
